Fig 1: Topical Application of 17-AAG Influences the Type 2 Immune Response in Mice with AD. (a) H&E- stained skin sections of naïve, vehicle- and 17-AAG-treated mice. Bars = 50 μm. (b) Relative expression of TSLP, IL-5, and IL-6 in the biopsies of mouse back skin, by qPCR. ELISA test results of (c) IgE level in the serum of mice and (d) NF-κB phosphorylation in the biopsies of mouse back skin. (e) Histological skin infiltration, as well as (f) the number of infiltrating leukocytes (CD45+), including (g) eosinophils (CD45+Siglec-F+) and (h) T helper cells (CD45+CD4+), were assessed in dissociated skin biopsies using flow cytometry. (i) Toluidine blue- stained skin sections of naïve, vehicle- and 17-AAG-treated mice. Bars = 50 μm. (j) Eosinophil proportion (% of WBC) in blood via hematology analyzer. (k) Histamine level in mouse serum, by ELISA. (l) Eosinophil peroxidase (EPX) activity, as measured by OPD assay in the back skin biopsies. Data are expressed as mean ± SEM (with individual values) or mean ± SD (in the case of epidermal thickness) of three independent experiments. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001; ns, no significance; H&E, Hematoxylin and Eosin; OPD, o-phenylenediamine dihydrochloride; OD, optical density; WBC, white blood cells; e, epidermis; d, dermis.
Fig 2: 17-AAG inhibits the expression of IL-33, the secretion of IL-6, T-helper cell-associated cytokines, and reactive oxygen species in cultures of activated human keratinocytes, CD4 + T lymphocytes, and eosinophils, respectively. TNF-α/IFN-γ- stimulated human keratinocytes (HaCaT) cells were cultured in presence of DMSO 0.1% (Vehicle) or various doses of 17-AAG. (a) Cell proliferation ELISA results as BrdU incorporation (%) after 6 h of incubation. (b) Relative expression of IL-33 and TSLP, by qPCR. (c) IL-6 levels in culture supernatant, by ELISA. (d) Phosphorylated STAT-1, STAT-3, and STAT-6 protein levels, corrected for β-Actin, were analyzed in HaCaT cell lysates following 1-hour or 24-hour activation using Western blot. Representative bands are presented. (e) NF-κB phosphorylation measured by ELISA. (f) FLG relative expression analyzed by qPCR. (g) IL-5, IL-17 A, and IL-22 secretion in the culture supernatant of anti-CD3/CD28 antibody-stimulated (1 µg/mL) CD4+ T cells derived from healthy donors, assessed by ELISA. (h) Luminol-enhanced ROS release in eosinophils derived from healthy donors, activated with fMLP (2 µM) or IL-33 (100 ng/mL). Data are presented as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001; ns, no significance; BrdU, BromodeoxyUridine; RLU, Relative Light Unit; AUC, Area Under Curve; ROS, Reactive Oxygen Species; OD, optical density.
Supplier Page from BioLegend for ELISA MAX™ Deluxe Set Human IL-5